The drugmaker is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday.
from mint - News https://ift.tt/3bWaHQ4
https://ift.tt/eA8V8J
from mint - News https://ift.tt/3bWaHQ4
https://ift.tt/eA8V8J
Post a Comment